Home / Netherlands / Lakefront Biotherapeutics NV
Lakefront Biotherapeutics NV
No short position is open on this share today.
0.00% of the capital sold short
0 disclosing funds
689 disclosures on record
Evolution of the disclosed total
0%1%2%3%
Oct 2025Jan 2026Apr 2026Jul 2026
July 31, 2015 today
Open positions
No fund discloses a short position on this share today. The history below keeps the trace of the ones that existed.
History of disclosures
| Date | Fund | % of capital | End of publication |
|---|---|---|---|
| July 21, 2020 | Citadel Advisors LLC | 0.50% | still open |
| July 20, 2020 | Citadel Advisors LLC | 0.49% | still open |
| July 13, 2020 | D. E. Shaw & Co., L.P. | 0.79% | still open |
| July 10, 2020 | D. E. Shaw & Co., L.P. | 0.80% | still open |
| July 9, 2020 | D. E. Shaw & Co., L.P. | 0.79% | still open |
| June 24, 2020 | Citadel Advisors LLC | 0.50% | still open |
| June 11, 2020 | Marshall Wace LLP | 0.82% | still open |
| June 2, 2020 | Marshall Wace LLP | 0.72% | still open |
| May 21, 2020 | Marshall Wace LLP | 0.69% | still open |
| May 18, 2020 | Marshall Wace LLP | 0.57% | still open |
| May 13, 2020 | Marshall Wace LLP | 0.68% | still open |
| May 11, 2020 | D. E. Shaw & Co., L.P. | 0.89% | still open |
| May 8, 2020 | Marshall Wace LLP | 0.71% | still open |
| April 29, 2020 | Marshall Wace LLP | 0.69% | still open |
| April 21, 2020 | Numeric Investors LLC | 0.47% | still open |
| April 16, 2020 | Marshall Wace LLP | 0.73% | still open |
| April 15, 2020 | D. E. Shaw & Co., L.P. | 0.99% | still open |
| April 15, 2020 | Marshall Wace LLP | 0.69% | still open |
| April 7, 2020 | D. E. Shaw & Co., L.P. | 1.00% | still open |
| April 7, 2020 | Marshall Wace LLP | 0.73% | still open |
| April 7, 2020 | Numeric Investors LLC | 0.51% | still open |
| April 6, 2020 | Marshall Wace LLP | 0.69% | still open |
| March 27, 2020 | Numeric Investors LLC | 0.49% | still open |
| March 26, 2020 | Marshall Wace LLP | 0.78% | still open |
| March 24, 2020 | Numeric Investors LLC | 0.59% | still open |
| March 23, 2020 | Marshall Wace LLP | 0.84% | still open |
| March 20, 2020 | Marshall Wace LLP | 0.90% | still open |
| March 20, 2020 | Citadel Advisors LLC | 0.45% | still open |
| March 19, 2020 | Marshall Wace LLP | 1.04% | still open |
| March 19, 2020 | Numeric Investors LLC | 0.69% | still open |
| March 18, 2020 | Citadel Advisors LLC | 0.57% | still open |
| March 17, 2020 | Marshall Wace LLP | 1.25% | still open |
| March 17, 2020 | D. E. Shaw & Co., L.P. | 0.90% | still open |
| March 17, 2020 | Numeric Investors LLC | 0.71% | still open |
| March 16, 2020 | Citadel Advisors LLC | 0.69% | still open |
| March 12, 2020 | Marshall Wace LLP | 1.39% | still open |
| March 12, 2020 | D. E. Shaw & Co., L.P. | 0.87% | still open |
| March 12, 2020 | Numeric Investors LLC | 0.53% | still open |
| March 11, 2020 | Marshall Wace LLP | 1.40% | still open |
| March 10, 2020 | Marshall Wace LLP | 1.38% | still open |
| March 9, 2020 | Marshall Wace LLP | 1.40% | still open |
| March 9, 2020 | D. E. Shaw & Co., L.P. | 0.96% | still open |
| March 3, 2020 | D. E. Shaw & Co., L.P. | 1.04% | still open |
| March 2, 2020 | Marshall Wace LLP | 1.30% | still open |
| February 28, 2020 | Marshall Wace LLP | 1.29% | still open |
| February 28, 2020 | D. E. Shaw & Co., L.P. | 0.96% | still open |
| February 27, 2020 | Citadel Advisors LLC | 0.79% | still open |
| February 26, 2020 | Marshall Wace LLP | 1.31% | still open |
| February 26, 2020 | Citadel Advisors LLC | 0.88% | still open |
| February 25, 2020 | Numeric Investors LLC | 0.39% | still open |
Other companies sold short in the Netherlands
- Signify N.V. 10.08% of the capital sold short
- Akzo Nobel N.V. 8.44% of the capital sold short
- Pharming Group N.V. 8.11% of the capital sold short
- The Magnum Ice Cream Company N.V. 6.43% of the capital sold short
- Imcd N.V. 5.61% of the capital sold short
- Basic-Fit N.V. 4.23% of the capital sold short
- Fugro N.V. 4.13% of the capital sold short
- DSM-Firmenich AG 3.65% of the capital sold short
- PostNL N.V. 3.07% of the capital sold short
- Alfen N.V. 2.27% of the capital sold short
- Shell plc 2.05% of the capital sold short
- Arcadis N.V. 1.76% of the capital sold short
Cite this page
The figure comes from the regulator register, not from this site. Quoting both lets your reader check it.
QuiVad, Lakefront Biotherapeutics NV, source AFM, data as at April 2, 2026, https://www.quivad.com/action/lakefront-biotherapeutics-nv?page=6